31 Jan Matthias Zachert leaves Merck KGaA and the stock drops …read more Source: Matthias Zachert leaves Merck KGaA and the stock drops 0 No comments admin blog Aveo’s cancer drug circles the drain after a scuttled Phase II trial Amgen outpaces its rivals in the race for a PCSK9 blockbuster